IA
DCPH

IFP Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

IFP Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-280
Closed -$6K – 4096
2018
Q1 		$6K Hold
280
– – ﹤0.01% 3106
2017
Q4 		$6K Buy
+280
New +$5.48K ﹤0.01% 3152

Other funds holding DCPH

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

IFP Advisors's DCPH Position: Q2 2018 in Review

IFP Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2018, closing a stake of 280 shares — an estimated $6K sold.

IFP Advisors first reported a position in DCPH in Q4 2017 and held it in 2 quarters. The position peaked at $6K in Q1 2018. 89 funds tracked by Wall St. Rank hold DCPH as of Q2 2018.

  • IFP Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • IFP Advisors sold 280 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2018, an estimated $6K.
  • IFP Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • IFP Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $6K in Q1 2018.
  • 89 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2018.

Based on IFP Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.